Norland Elite 437A150, Operator'S Manual

Page: 454 / 490

Lymphoma: Grounds for exclusion.
Malabsorption Syndromes: Grounds for exclusion.
Multiple Myeloma: Grounds for exclusion.
Paget’s Disease: Data collected from these subjects will be excluded.
Renal Dialysis: Data collected from subjects on dialysis will be excluded.
Renal Disease: Renal disease without dialysis is not grounds for exclusion from the study. Subject is included
if Creatnine is less than 2 and excluded if creatnin is more than 2. If Creatnine level is unknown, subject will be
excluded.
Smoking: Not grounds for exclusion. However, please note current smoking habits and past smoking history,
which includes amount and time frame.
Sickle Cell: Not grounds for exclusion.
Tuberculosis: Only grounds for exclusion if disease is active.
Vitamin Deficiencies: Not grounds for exclusion, but such deficiencies should be noted and explained.
Medications Affecting Bone
The use of medications affecting bone are possible grounds for exclusion. Such medications include:
Anticonvulsants: Grounds for exclusion.
Birth Control Pills: In general, birth control pills are not grounds for exclusion. Some postmenopausal subjects
will report perimenopausal estrogen replacement therapy as “birth control pills” probably because of a com-
parison made by their physician. These subjects will not be excluded for estrogen use.
Bisphosphonates: Bisphosphonates are grounds for exclusion. Individuals currently using Bisphosphonates
or those who have for less than six (6) months will be excluded. For those with a past history, please note med-
ication, duration, dose and time frame on Medical History form.
Calcitonins: Calcitonins are grounds for exclusion. Individuals currently using Calcitonins or those who have
ever used Calcitonins for more than six (6) months will be excluded. For those with a past history, please note
medication, duration, dose and time frame on Medical History form.
Dilantin: Grounds for exclusion.
Estrogen: HRT and ERT are grounds for exclusion.
Note: Individuals currently on ERT or HRT: Those on ERT or HRT for less than three (3) months can
be included in the study. Individuals who have been on HRT or ERT in the past: If it has been more
than 24 months since treatment ended, the subject’s data can be included in the study.
Heparin: Grounds for exclusion if taken for more than three (3) months.
Sodium Fluorides: Sodium Fluorides are grounds for exclusion. Individuals currently using Sodium Fluoride or
those who have ever used Sodium Fluorides for more than six (6) months will be excluded. For those with a
past history, please note medication, duration, dose and time frame on Medical History form.
Steroids: Oral and inhaled steroids are criteria for possible exclusion. Those on high dose (>3 mos.) will be
excluded. Please note medication, duration, dose, and time frame on history. (Site specific injections are not
grounds for exclusion.)
Thyroid Hormone: Not grounds for exclusion if proper dose is given; these actually compensate for an abnor-
mal condition. Subjects will be excluded if dosage has changed within the last twelve months.
Operator's Guide
437D140 Rev. I
18-4 Reference Data Sets